Skip to main content
Veterinary Medicines

SYNULOX VET 140 mg/ml injektioneste, suspensio koiralle, kissalle ja sialle

Authorised
  • Amoxicillin
  • Clavulanic acid

Product identification

Medicine name:
SYNULOX VET 140 mg/ml injektioneste, suspensio koiralle, kissalle ja sialle
Active substance:
  • Amoxicillin
  • Clavulanic acid
Target species:
  • Dog
  • Cat
  • Pig
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Amoxicillin
    140.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Clavulanic acid
    35.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
    • Pig
      • Meat and offal
        29
        day
  • Subcutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Authorisation status:
  • Valid
Authorised in:
  • Finland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Animal Health ApS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 12197
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 3/01/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 3/01/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."